Revenue increased 13.3%
Revenue changed +13.3% from the comparable as-filed period.
$2.8B→$3.1B2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MSI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 79 bp higher
Operating margin changed +79 basis points from the comparable as-filed period.
25.03%→25.82%2 prior comparisons
Free-cash-flow margin moved 508 bp higher
Free-cash-flow margin changed +508 basis points from the comparable as-filed period.
8.14%→13.21%2 prior comparisons
Operating cash-flow margin moved 510 bp higher
Operating cash-flow margin changed +510 basis points from the comparable as-filed period.
9.87%→14.97%2 prior comparisons
Stock-based compensation increased 40.5%
Stock-based compensation changed +40.5% from the comparable as-filed period.
$74.0M→$104.0M2 prior comparisons
Working capital / assets moved 1693 bp lower
Working capital / assets changed -1693 basis points from the comparable as-filed period.
19.80%→2.87%3 prior comparisons
Total assets increased 17.2%
Total assets changed +17.2% from the comparable as-filed period.
$16.4B→$19.2B3 prior comparisons
Gross profit increased 18.8%
Gross profit changed +18.8% from the comparable as-filed period.
$1.4B→$1.7B2 prior comparisons
Shares outstanding decreased 0.7%
Shares outstanding changed -0.7% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
166,603,894→165,493,7888 prior comparisons
Trade receivables increased 16.6%
Trade receivables changed +16.6% from the comparable as-filed period.
$1.9B→$2.2B3 prior comparisons
Operating cash flow / net income increased 58.2%
Operating cash flow / net income changed +58.2% from the comparable as-filed period.
0.53→0.842 prior comparisons
Noncurrent long-term debt increased 9.9%
Noncurrent long-term debt changed +9.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$7.7B→$8.4B4 prior comparisons
Net income increased 8.6%
Net income changed +8.6% from the comparable as-filed period.
$513.0M→$557.0M2 prior comparisons
Receivables / revenue moved 196 bp higher
Receivables / revenue changed +196 basis points from the comparable as-filed period.
66.98%→68.94%2 prior comparisons
Research & development increased 12.6%
Research & development changed +12.6% from the comparable as-filed period.
$231.0M→$260.0M2 prior comparisons
SBC / revenue moved 64 bp higher
SBC / revenue changed +64 basis points from the comparable as-filed period.
2.68%→3.32%2 prior comparisons
Selling, general & administrative increased 10.2%
Selling, general & administrative changed +10.2% from the comparable as-filed period.
$450.0M→$496.0M2 prior comparisons
Capex / revenue moved 2 bp higher
Capex / revenue changed +2 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.74%→1.76%2 prior comparisons
Capital expenditure increased 14.6%
Capital expenditure changed +14.6% from the comparable as-filed period.
$48.0M→$55.0M2 prior comparisons
R&D / revenue moved 6 bp lower
R&D / revenue changed -6 basis points from the comparable as-filed period.
8.35%→8.30%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.